NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88 | -2.2% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $90 | -25.0% | 12,100 | -30.0% | 0.00% | 0.0% |
| Q1 2023 | $120 | -33.7% | 17,293 | -2.0% | 0.00% | -50.0% |
| Q4 2022 | $181 | -99.9% | 17,643 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $321,000 | -64.2% | 17,643 | +1.1% | 0.00% | -62.5% |
| Q2 2022 | $897,000 | -30.6% | 17,443 | -0.6% | 0.01% | -20.0% |
| Q1 2022 | $1,292,000 | -71.7% | 17,546 | -45.1% | 0.01% | -41.2% |
| Q4 2021 | $4,572,000 | +51.9% | 31,960 | +120.1% | 0.02% | -32.0% |
| Q3 2021 | $3,010,000 | -7.6% | 14,521 | -5.3% | 0.02% | -3.8% |
| Q2 2021 | $3,256,000 | +199.5% | 15,337 | +155.7% | 0.03% | -36.6% |
| Q1 2021 | $1,087,000 | +50.1% | 5,997 | -7.7% | 0.04% | +51.9% |
| Q4 2020 | $724,000 | +3.3% | 6,497 | +0.4% | 0.03% | -10.0% |
| Q3 2020 | $701,000 | +35.9% | 6,474 | +4.6% | 0.03% | +25.0% |
| Q2 2020 | $516,000 | – | 6,191 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |